SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter R Smith who wrote ()5/23/2000 11:11:00 AM
From: scott_jiminez  Read Replies (2) of 675
 
Talk about your blue light special!

Since if appears the data from the original GGF2 paper (where it was shown to stabilize/reduce demyelination and enhance remyelination in a rodent model of MS) has held up to scrutiny in the 18 months since it was published ( ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9707607&dopt=Abstract), and CeNeS gets CNSI for only $2.25, man o man they just got away with just plain robbery.

Heck, the ongoing collaboration with Cedric Raine has got to be worth $2 a share alone!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News